Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life.
about
Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adultsEffects of Jianpi Qingchang decoction on the quality of life of patients with ulcerative colitis: A randomized controlled trial.Huangqin-Tang Ameliorates TNBS-Induced Colitis by Regulating Effector and Regulatory CD4(+) T CellsConventional drug therapy for inflammatory bowel disease.Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease.Maintenance therapy options for ulcerative colitis.Reviewing treatments and outcomes in the evolving landscape of ulcerative colitis.Mesalamine Enemas for Induction of Remission in Oral Mesalamine-refractory Pediatric Ulcerative Colitis: A Prospective Cohort Study.Adherence to Rectal Mesalamine in Patients with Ulcerative Colitis.Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies.Anorectal Dysfunction in Distal Ulcerative Colitis: Challenges and Opportunities for Topical Therapy.Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease.Albumin as a prognostic marker for ulcerative colitis.Inflammatory Bowel Disease: Pathophysiology and Current Therapeutic Approaches.
P2860
Q26768280-D6E3499C-54E0-462A-A251-27A43D158B3AQ33606202-9A0ED63E-1612-4185-8CED-24742A576EE3Q35963919-2A63AFA1-CA97-402A-9D3F-1B4AABBA7424Q38293796-3EF7F504-EFF8-4AF8-8D0B-611580B96D34Q38542147-03A4FBC6-992B-49B8-B892-7753A0DD72DFQ38848140-61E7E90C-A5B1-443A-B449-7DACDDF72163Q39251794-740FFCCE-2F1C-4E4E-B7ED-9C175D2CBD4DQ40261930-6E5816AE-17C9-4CB5-B43C-A473A56691FBQ40600605-83B76A48-20F4-412E-9828-57B2A0A31AACQ42414887-C77D2BD4-53DF-47B3-A5B5-8C7AC9852816Q42417823-B1D5C27D-7F63-4087-9741-E662D2A084E1Q42602745-DE300060-4EAE-4D11-A218-BD297629FB32Q47095157-92B39C29-B489-4387-A3D9-58F90EE8CC17Q47961270-DC8E6C02-D4A7-4362-AD4B-F9203631F03A
P2860
Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Combined oral and rectal mesal ...... provements in quality of life.
@en
Combined oral and rectal mesal ...... provements in quality of life.
@nl
type
label
Combined oral and rectal mesal ...... provements in quality of life.
@en
Combined oral and rectal mesal ...... provements in quality of life.
@nl
prefLabel
Combined oral and rectal mesal ...... provements in quality of life.
@en
Combined oral and rectal mesal ...... provements in quality of life.
@nl
P2093
P2860
P1476
Combined oral and rectal mesal ...... provements in quality of life.
@en
P2093
Axel U Dignass
Christopher S J Probert
Marco Oudkerk Pool
Philippe Marteau
Stefan Lindgren
P2860
P304
P356
10.1016/J.CROHNS.2013.08.007
P577
2013-09-04T00:00:00Z